From: Evaluating diagnostic strategies for early detection of cancer: the CanTest framework
Authors Year & setting | Framework | Field | Cancer-specific | Low prevalence population | Triage test | Diagnostic strategy | |
---|---|---|---|---|---|---|---|
GENERIC TEST FRAMEWORKS n = 8 | |||||||
1 | Fryback & Thornbury [12], 1991, USA | Hierarchical Model of Efficacy | Imaging | No | No | Yes | No |
2 | Harris et al. [14] 2001, USA | U.S. Preventive Services Task Force | Generic | No | Yes | No | N/S |
3 | Pepe et al.[15] 2001, USA | Phases of biomarker development for early detection of cancer | Laboratory medicine | Yes | No | No | No |
4 | Gazelle et al. [15] 2011, USA | Framework for assessing the vaue of diagnostic imaging | Imaging | No | No | No | N/S |
5 | Febbo et al. [13] 2011, USA | Evaluating the clinical utility of tumor markers in oncology. NCCN Task Force Report | Oncology | Yes | No | No | No |
6 | Ferrante Di Ruffano et al. [16] 2012, UK and international partners | Framework for designing and evaluating trials. | Generic | No | No | Yes | Yes |
7 | Horvath et al. [17] 2014, Australia | From biomarkers to medical tests: The changing landscape of test evaluation. | Laboratory medicine | No | No | Yes | Yes |
8 | Thompson et al. [18] 2016, USA | Framework to incorporate multiple test attributes in evaluating diagnostic tests including Point-of-Care tests. | Generic | No | Yes | N/S | N/S |
TESTS SPECIFIC TO EVAULATING GENETIC TESTS n = 6 | |||||||
9 | Phillips et al. [4] 2006 USA | Diagnostics and biomarker development: priming the pipeline. | Pharmacogenetics | No | No | No | No |
10 | Teutsch et al. [19] 2009, USA | Evaluation of Genomic Applications in Practice and Prevention- the EGAPP Framework. | Genetics | No | Yes | No | No |
11 | Rosenkötter et al. [20] 2011, European | The Contribution of Health Technology Assessment, Health Needs Assessment, and Health Impact Assessment to the Assessment and Translation of Technologies in the Field of Public Health Genomics. | Genetics | No | N/S | No | No |
12 | Rousseau et al. [21] 2010, Canada | Development and description of GETT: a Genetic testing Evidence Tracking Tool. | Genetics | No | N/S | N/S | No |
13 | Sun et al. [22] 2013, USA | Evaluation frameworks and assessment of analytic validity. | Genetics | No | N/S | No | N/S |
14 | Lin et al. [23] 2012, USA, UK | Evaluating genomic tests from bench to bedside: a practical framework. | Genetics | No | Yes | No | N/S |
OTHER FRAMEWORKS n = 2 | |||||||
15 | Singh & Sittig [24], 2015, USA | Safer Dx Framework. | Generic | No | N/S | Yes | Yes |
16 | Price & St John [25], 2014, UK & international partners | Anatomy of value proposition for laboratory medicine. | Laboratory medicine | No | N/S | Yes | Yes |